toxicity management for third-line therapy for mcrc
Published 7 years ago • 57 plays • Length 5:03Download video MP4
Download video MP3
Similar videos
-
5:03
mcrc: options for third-line therapy
-
3:30
mcrc: options for third-line therapy and beyond
-
15:47
management of adverse events associated with third-line mcrc treatments
-
8:39
third-line therapy for metastatic colorectal cancer
-
7:35
treatment options for third-line therapy in mcrc
-
4:08
case 3: third-line therapy for metastatic crc
-
5:52
third-line therapy for metastatic colon cancer
-
1:47
hai therapy: game changer for colon cancer patients
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
5:02
third-line treatment options for mcrc
-
5:55
options for third-line therapy in metastatic crc
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
53:57
live discussion: new third line treatment for mcrc
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
11:02
debate 3: salvage therapy for mcrc? - regorafenib
-
4:44
treatment beyond progression for mcrc
-
1:47
new treatment option for metastatic colorectal cancer prolongs survival
-
6:00
metastatic colorectal cancer: multiple lines of therapy
-
3:11
mcrc: third-line treatment decisions